Predictions
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€75.79
08.02.16
08.02.16
€100.00
28.04.16
28.04.16
14.98%
28.04.16
28.04.16
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€43.99
06.02.16
06.02.16
€100.00
08.08.16
08.08.16
39.26%
08.08.16
08.08.16
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€22.01
05.02.16
05.02.16
€45.00
05.08.16
05.08.16
-7.31%
05.08.16
05.08.16
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.35
03.02.16
03.02.16
€90.00
09.02.17
09.02.17
-18.07%
09.02.17
09.02.17
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€76.75
02.02.16
02.02.16
€117.26
31.10.16
31.10.16
-11.45%
31.10.16
31.10.16
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€49.66
02.02.16
02.02.16
€55.02
02.08.16
02.08.16
5.42%
02.08.16
02.08.16
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€74.59
29.01.16
29.01.16
€91.55
23.01.17
23.01.17
-11.89%
23.01.17
23.01.17
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€7.93
25.01.16
25.01.16
€19.84
08.02.16
08.02.16
-19.34%
08.02.16
08.02.16
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€426.53
21.01.16
21.01.16
€676.50
21.07.16
21.07.16
-5.05%
21.07.16
21.07.16
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.52
20.01.16
20.01.16
€16.70
09.02.16
09.02.16
2.75%
09.02.16
09.02.16
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€14.56
20.01.16
20.01.16
€17.50
21.07.16
21.07.16
-32.35%
21.07.16
21.07.16